Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$3.1M
Net $1.6M sold
Sales
$1.6M
1 transaction
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Tessari Eben
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Oct 1, 2025
- Transaction Date
- Sep 29, 2025
- Accession Number
- 0001867899-25-000005
- Form Type
- 4
- Net Trading Amount
- -$1.6M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 29, 2025 | Class A Ordinary Share | 42,000 | $17.92 | Exercise | $752.6K |
| Sep 29, 2025 | Class A Ordinary Share | 42,000 | $38.33 | Sale | $1.6M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Sep 29, 2025 | Derivative | 42,000 | $17.92 | Exercise | $752.6K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $37.92 and $38.85. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)The option is fully vested and exercisable.